Here, we found prostaglandin E synthase 2 (PTGES2), one key enzyme catalyzing the synthesis of prostaglandin E2, which was associated with the progression of some tumors, such as colorectal cancer (CRC), hepatocellular carcinoma (HCC), and RCC (36–38). This evidence concerns the gene PTGES2 and renal cell carcinoma.